6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
2m ago	The Joint Corp. Announces Milind Pant Elected as Director
2m ago	Verizon Announces Preliminary Shareholder Voting Results from 2026 Annual Meeting
2m ago	Tiderock Companies Reports First Quarter 2026 Results as Tiderock Composites Manufacturing Revenue Increases 46% Year Over Year
3m ago	LPL Financial Welcomes True Compass Advisors
3m ago	Varonis Announces Integration with the Claude Compliance API

About

14.14AUD+0.14 +1.00%

Closed • Updated at 17:38 GMT+00:00

Market Cap$3.40B

Volume2.26M

Beta0.75

RSI45.87

Gross Margin53.15%

Health TechnologyBiotechnology

Telix Pharmaceuticals Limited — investor relations, events, news, and company updates on 6ix.

Latest News

IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing

Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches

New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC

TLX101-Px (Pixlumi®) MAA Accepted in Europe

OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer

Community Chat

Ask AI